Want to see SG:8K7 full AI Analyst Report?
UG Healthcare Corp. Ltd. (8K7) AI Stock Analysis
UG Healthcare Corp. Ltd.
(SGX:8K7)
The score is driven primarily by improving financial performance (return to profitability and positive free cash flow) and a generally sound balance sheet with moderate leverage. Offsetting this, profitability and returns remain low and historically volatile, while technical signals are mixed with the price still below longer-term moving averages. Valuation (P/E ~22.94) is not especially compelling given current margin/ROE levels, and no dividend yield data is available to provide additional support.
UG Healthcare Corp. Ltd. (8K7) vs. iShares MSCI Singapore ETF (EWS)
- Market Cap
- SGD 46.79M
- Dividend Yield
- ―
- Average Volume (3M)
- 161.94K
- Price to Earnings (P/E)
- 22.1
- Beta (1Y)
- 0.36
- Revenue Growth
- 4.69%
- EPS Growth
- ―
- Country
- Singapore
- Employees
- 743
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Instruments & Supplies
UG Healthcare Corp. Ltd. Business Overview & Revenue Model
Company Description
UG Healthcare Corporation Limited, an investment holding company established in Singapore in 1989, primarily engages in the manufacturing and worldwide distribution of disposable gloves. Its business is structured across three main segments: Latex Ex...
UG Healthcare Corp. Ltd. Financial Statement Overview
Summary
FY2026 shows a recovery with revenue up ~4.7%, improved gross margin (~28.4%), and a return to positive operating profit and net income after FY2024–FY2025 losses. Operating and free cash flow turned positive (~17.6m OCF, ~15.0m FCF), improving flexibility. Offsetting this, profitability remains thin (net margin ~1.4%, operating margin ~3.7%), ROE is low (~1.2%), and results have been volatile versus earlier peak years.
Income Statement
52NeutralBalance Sheet
72PositiveCash Flow
63Positive| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 94.93M | 150.82M | 144.07M | 115.20M | 101.13M | 232.60M |
| Gross Profit | 3.43M | 42.87M | 34.74M | 25.87M | 1.45M | 84.39M |
| EBITDA | -21.20M | 11.41M | 2.47M | -3.94M | -23.97M | 53.37M |
| Net Income | -20.93M | 2.10M | -3.79M | -6.06M | -20.73M | 36.80M |
Balance Sheet | ||||||
| Total Assets | 215.39M | 240.52M | 232.35M | 226.45M | 230.00M | 288.04M |
| Cash, Cash Equivalents and Short-Term Investments | 45.13M | 27.41M | 23.29M | 28.00M | 61.74M | 100.22M |
| Total Debt | 28.46M | 40.52M | 47.36M | 43.72M | 31.13M | 17.98M |
| Total Liabilities | 44.08M | 70.75M | 76.03M | 65.17M | 48.81M | 52.98M |
| Stockholders Equity | 171.94M | 171.76M | 158.73M | 163.39M | 180.84M | 228.90M |
Cash Flow | ||||||
| Free Cash Flow | -36.98M | 14.97M | -8.11M | -20.71M | -47.17M | 31.63M |
| Operating Cash Flow | -34.35M | 17.59M | -4.78M | -18.16M | -39.14M | 53.95M |
| Investing Cash Flow | -2.63M | -2.62M | -3.21M | -22.73M | -8.03M | -21.19M |
| Financing Cash Flow | 4.62M | -11.20M | 3.24M | 8.36M | 8.70M | -973.00K |
UG Healthcare Corp. Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:8K7, the sentiment is Positive. The current price of 0.07 is below the 20-day moving average (MA) of 0.08, below the 50-day MA of 0.08, and below the 200-day MA of 0.08, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 59.17 is Neutral, neither overbought nor oversold. The STOCH value of 138.89 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SG:8K7.
UG Healthcare Corp. Ltd. Peers Comparison
Overall Rating
SG:OTX66Neutral- SG:8K757Neutral
Financial Indicators
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SG:8K7 | UG Healthcare Corp. Ltd. | 0.07 | -0.03 | -25.00% | |
| SG:1J5 | Hyphens Pharma International Ltd. | 0.36 | 0.02 | 4.65% | |
| SG:505 | Asiamedic Limited | 0.02 | -0.00 | -19.05% | |
| SG:546 | Medtecs International Corporation Ltd. | 0.10 | -0.02 | -18.40% | |
| SG:MIJ | Alliance Healthcare Group Ltd. | 0.18 | 0.07 | 62.16% | |
| SG:OTX | Medinex Ltd. | 0.20 | -0.02 | -8.26% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 29, 2026